Apoptosis describes the morphological changes that identify a specific form of regulated cell death. Over recent years, the importance of either aberrant onset or suppression of apoptosis within tissues has become apparent and is associated with the development of several terminal diseases. Here we describe the relevance of apoptosis to the maintenance of vascular homeostasis. Specifically, we address the role of vascular smooth muscle cell death, how this may be regulated at the molecular level and whether any of these molecular mediators will provide targets for intervention in diseases such as atherosclerosis.
Introduction
death and proliferation are two very tightly linked pathways. This paradoxical coupling safeguards the organism Apoptosis or programmed cell death is a process against cellular mutations that lead to unrestrained cell through which multicellular organisms efficiently dispose growth. A cell may acquire a mutation in a gene that of cells. Since its initial description as a series of morpromotes cell growth; however, this will also promote the phological events, much has been discovered about the death of the cell in the absence of survival factors, which molecular control of apoptosis. Along with the identificaare in limited supply in vivo. Thus, diseases that exhibit tion of genes that act to modulate this pathway has come excess cellular accumulation are likely to have attained the knowledge that regulation of cell death is critical for lesions that uncouple the link between proliferation and the maintenance of tissue homeostasis. Moreover, it is death. Conversely, diseases that exhibit increased cell apparent that all cells are programmed to die. Indeed, cell death are likely to have become more sensitive to apoptotic death is their default state, which can be suppressed stimuli possibly due to a defect in survival signalling through the expression or presence of intracellular and pathways, or a defect in the regulation of cell cycle extracellular survival factors. It may seem strange that cells control. can be lost so easily from tissues. However, for long-lived Although the above arguments are generally well acmulticellular organisms it makes much biological sense to cepted in areas such as tumour biology, they have not yet dispose rapidly of cells that, for whatever reason, may be been fully investigated in vascular biology. Vascular leof no use or potentially harmful. This is now very evident sions such as atherosclerosis and restenosis after angioplasfrom work on genes that regulate cell cycle. Tumour ty arise in part from excessive accumulation of vascular suppressor genes such as RB and p53 and oncogenes such smooth muscle cells (VSMCs), which may suggest reas c-myc that one would primarily associate with reguladuced apoptosis in the diseased tissue. When vessels tion of cell proliferation also induce cell death. Indeed, remodel either in physiological or pathological conditions, apoptosis and cell proliferation are intimately coupled. However, vascular atrophy in aneurysm formation is accompanied by excessive apoptosis. Thus, too little and channel blockers can modify the contribution of apoptosis, too much apoptosis within the vessel wall may be deleteriindependently of the blood pressure fall [9, 10] . ous. This review seeks to analyse the evidence for VSMC apoptosis in vascular diseases, and identify potential 2.2. Arterial injury regulatory pathways involved.
Acute arterial injury, such as that occurring at angioplasty, is followed by rapid induction of medial cell apoptosis, 2. Cell proliferation and death in the vascular wall at least in animal models. Thus, in rat or rabbit vessels, balloon overstretch injury results in medial cell apoptosis Vascular smooth muscle cells within the vessel wall are from 30 min-4 h after injury [12] [13] [14] . In pigs, apoptotic able to proliferate, migrate, synthesise and degrade excells occur within the media at 6 h with peaks in the tracellular matrix upon receiving appropriate stimuli. In the media, adventitia, and neointima at 18 h, 6 h, and 7 days undiseased wall cells are party to all the normal controls after PTCA, respectively [15] . Although we have no direct that govern cell proliferation and death, such as the evidence, the consistency of this response in animal presence of survival factors and mitogens, cell to cell models suggest that human vessels may behave similarly. contact inhibition and cell-matrix interactions. The normal Repair of the vessel after injury is also associated with adult artery shows very low levels of VSMC turnover, thus VSMC apoptosis, both in the media and in the intima, and apoptotic and mitotic indices are low in this tissue [1] . In in the rat occurs 8-21 days after injury [16] . In humans, diseased tissue additional factors are present both locally, restenosis after angioplasty has been reported to be associsuch as inflammatory cytokines, inflammatory cells and the ated with either an increase [17], or decrease [18] in presence of modified cholesterol, and systemically, such as VSMC apoptosis. The role of VSMC apoptosis in either blood pressure and flow. These factors can substantially the initial injury or the remodelling process in restenosis is alter the normal balance of cell proliferation and apoptosis, still unclear in human vessels. although the degree to which they are altered is dependent upon the vascular disease under study.
2.3. Aneurysm formation
Remodelling
The commonest form of arterial aneurysm in humans is associated with advanced atherosclerosis, and is characterVessel wall remodelling defines a condition in which ised by a loss of VSMCs from the vessel media, with alterations in luminal size can occur through processes that fragmentation of elastin and matrix degradation, leading to do not necessarily require large changes in overall cell progressive dilatation and eventually rupture. Apoptosis of number or tissue mass. Thus, redistribution of cells, either VSMCs is increased in aortic aneurysms [19] [20] [21] comtowards or away from the lumen, through processes such pared with normal aorta and is associated with an increase as selective cell proliferation / apoptosis or matrix synin expression of a number of pro-apoptotic molecules, such thesis / degradation can significantly alter lumen dimenas death receptors and p53 [19, 21] . Macrophages and sions. Physiological remodelling occurs in closure of the T-lymphocytes are found in aneurysmal lesions, suggesting ductus arteriosus due to the reduction in blood flow [2] , that inflammatory mediators released by these cells may and reduction in lumen size of infra-umbilical arteries after increase the loss of cells from these areas. Moreover, the birth [3, 4] . Surgical reduction in flow also results in production of tissue metalloproteinases by macrophages compensatory reduction in VSMC numbers by apoptosis may accelerate cell death by degrading the extracellular [5, 6] . Remodelling also occurs in primary atherosclerosis, matrix from which VSMCs derive survival signals (see after angioplasty and in angioplasty restenosis. Although below). apoptosis undoubtedly occurs in all of these conditions (see below), the role of VSMC apoptosis in determining the 2.4. Atherosclerosis outcome of remodelling is unclear.
A further example of vessel remodelling accompanied Rupture of atherosclerotic plaques is associated with a by VSMC apoptosis comes from studies examining both thinning of the VSMC-rich fibrous cap overlying the core. development and regression of vessel hypertrophy / hyRupture occurs particularly at the shoulder regions of perplasia in hypertension. Hypertension is associated with plaques, which are noted for their lack of VSMCs and the VSMC apoptosis in cells from SHR rats [7] and in SHR presence of macrophages and other inflammatory cells. rats as hypertension develops [8, 9] . In addition, relief of Unsurprisingly then, apoptotic VSMC are evident in adeither systemic or pulmonary hypertension results in vanced human plaques [17, 22, 23] , including the shoulder apoptosis of VSMCs in the affected artery, with evidence regions, prompting the suggestion that VSMC apoptosis that some antihypertensives are more potent than others may hasten plaque rupture. Indeed, there is evidence of [9] [10] [11] . In particular, angiotensin converting enzyme inincreased VSMC apoptosis in unstable versus stable angina hibitors, angiotensin II receptor antagonists and calcium lesions [18] . However, there is no direct evidence of the effect of apoptosis per se in the advanced human lesion. [34] . The demonstration that apoptosis releases active Most apoptotic cells in histological sections are found in molecules rather negates the idea of apoptosis as a 'silent' advanced lesions next to the lipid core [24] and it is still mechanism of deleting cells. However, apoptotic cells that not clear how many of these apoptotic cells are macroare not rapidly phagocytosed will begin to release inphages or VSMC. Loss of macrophages from atherosflammatory cytokines as they undergo secondary necrosis. clerotic lesions is likely to promote plaque stability rather This release of inflammatory cytokines will result in the than rupture, since macrophages can promote VSMC recruitment of monocytes and macrophages to the surapoptosis by both direct interactions [25] and by release of rounding area. This may well occur to allow phagocytosis cytokines [26] . Of interest, apoptosis also occurs in early of a large number of apoptotic cells that cannot be stages of atherosclerosis induced by cholesterol feeding in efficiently disposed of by surrounding healthy smooth animals, at the fatty streak stage of before morphological muscle cells [35] . In atherosclerosis, inefficient phagoevidence of lesion formation [27] . Again, the effect of cytosis of dead cells may occur due to the presence of apoptosis at this early stage of lesion development is modified LDL, which hampers phagocytosis of apoptotic unknown.
cells [36] . Thus, it may be that death is initially silent in atherosclerotic lesions but as corpses mount up and 2.5. Effect of VSMC apoptosis professional phagocytes are impeded by modified LDL, more inflammatory cells may be recruited. Moreover, The effect of VSMC apoptosis is clearly context-depensoluble death ligands such as Fas-L are released from the dent. Thus, VSMC apoptosis in advanced atherosclerotic surface of monocyte / macrophages as they phagocytose, plaques would be expected to promote plaque rupture resulting in bystander death of adjacent neutrophils or (although there is as yet no direct evidence that it does so), monocytes [37] , enhancing the deficit of professional and medial atrophy in aneurysm formation (where there is phagocytic cells. There exists therefore the potential for the more evidence of such). In neointima formation post death and subsequent phagocytosis of apoptotic cells in injury, VSMC apoptosis of both the intima and media can atherosclerotic plaques to trigger further apoptosis, setting limit neointimal formation [13,14,28] at a defined time up a positive feedback loop. point (although long term studies have not been performed to ensure that the neointima is not simply delayed). It is not yet known whether such inhibition of neointimal 3. Regulation of VSMC apoptosis formation in an animal model can translate into suppression of restenosis following angioplasty or stenting, but the 3.1. Apoptosis via death receptors evidence suggesting that most of angioplasty restenosis occurs through remodelling [29] and the near total failure Many stimuli can trigger apoptosis in cells, but in of anti-proliferative therapy to inhibit restenosis does not vascular disease it is likely that specific alterations within augur well.
the VSMC itself elicit sensitivity to a particular stimulus Therapeutic induction of apoptosis in the vessel wall that is disease-associated. Thus, remodelling may trigger may also be limited by important sequelae. In contrast to apoptosis following reduction in blood flow, and the major the prevailing notion that apoptotic deaths are effectively stimulus may therefore be flow-dependent stimuli such as silent (that is, they do not elicit an immune response) a nitric oxide or shear stress. In contrast, apoptosis in number of deleterious effects of apoptotic cells have atherosclerosis or aneurysm formation may be due to the emerged within the vasculature. First, the exposure of surrounding influences of inflammatory cells that express phosphatidylserine on the surface of apoptotic cells prodeath ligands on their surface or secrete pro-apoptotic vides a potent substrate for the generation of thrombin and cytokines. The external triggers for apoptosis in many of activation of the coagulation cascade [30, 31] . Apoptotic these disease states have been reviewed recently [38, 39] . cells release membrane-bound microparticles into the Here, we will review the potential machinery by which an circulation which remain pro-coagulant and are increased apoptotic stimulus may be transmitted and executed within in patients with unstable versus stable coronary syndromes
VSMCs by comparing the data from VSMC models with [32, 33] . Although apoptotic cells are not the only source of other well established cell models of apoptosis. circulating microparticles, such micro-particles may con-
The regulation of apoptosis within the cell can be tribute to the increased pro-coagulant state in these simplified into two major pathways ( Figs. 1 and 2) . First, syndromes. Apoptotic VSMCs can also release both membrane-bound death receptors of the tumour necrosis mitogens (bFGF) and pro-inflammatory cytokines such as receptor family (TNF-R), such as Fas (CD95), TNF-R1, MCP-1 resulting in recruitment of monocytes [34] , both of death receptor (DR)-3, DR4 and DR5 bind their trimerised which may abrogate any direct reduction in neointima ligands causing receptor aggregation, and subsequent formation. Indeed, in some studies massive induction of recruitment of a number of adapter proteins through apoptosis in intimal VSMCs may reduce cell density but protein: protein interactions [40] (see Fig. 1 ). For example, not overall neointimal size or increase lumen dimensions binding of agonistic anti-Fas monoclonal antibody or its natural ligand Fas-ligand to its cognate receptor induces complex [41] [42] [43] . In turn, FADD and RIP recruit cell receptor trimerisation, with subsequent recruitment of death cysteine proteases (caspases) such as caspase 8 adapter molecules such as FADD and RIP to the receptor (FLICE) and caspase 2 to the complex [44] . Within the complex of Fas, FADD and caspase 8 (known as the In contrast, IAPs can inhibit the enzymatic activity of death-inducing signalling complex (DISC)), caspase 8 downstream caspases [60] [61] [62] (see below), or they can becomes proteolytically activated by oligomerisation [45] .
mediate anti-apoptotic signalling pathways through the This facilitates the subsequent activation of terminal activation of nuclear transcription factor B (NF-kb) [63] . effector caspases such as caspases 3, 6 and 7 [46] [47] [48] [49] [50] Human VSMCs express both Fas and TNF-R1 [64] , and responsible for cleavage of intracellular substrates required given the widespread occurrence of TRAIL-Rs are also for cellular survival, architecture and metabolic function likely to express these receptors. T-lymphocytes and [51, 52] . Caspase activation is also responsible for many of macrophages within the atherosclerotic plaque express the hallmarks of apoptosis, such as DNA fragmentation, CD95 ligand and TNF-a, and interaction between memchromatin condensation and apoptotic body formation [53- brane [56] , caspase 8 activation causes cleavage of tosis in the absence of 'priming' of the cell, usually with proteins of the bcl-2 family such as bid [57] (see Fig. 2 ).
cycloheximide. Some of this resistance can be explained Bcl-2 family members are characterised as either proby the observation that death receptors are sequestered apoptotic (Bax, Bid, Bik, Bak) or anti-apoptotic (Bcl-2, intracellularly in VSMCs [66] , and priming may be associBcl-X ). Activation of pro-apoptotic Bcl-2 family memated with increased surface expression. Physiologically, L bers causes their translocation to mitochondria, where they increased death receptor expression can be achieved via interact with anti-apoptotic members that are components combination of cytokines such as IL-1-b, IFN-g and TNFof the mitochondrial membrane. This interaction causes a [64, 67, 68] , possibly via NO and p53 stabilisation changes in voltage-dependent mitochondrial channels and [26, [68] [69] [70] , or via direct activation of p53 [66] . Free releases mitochondrial mediators of apoptosis such as radicals and NO can also induce apoptosis which may be cytochrome c [58] . In turn the association of cytochrome c independent of p53 but associated with caspase 3 activawith an adapter molecule apaf-1 and caspase 9 activates tion [71] [72] [73] [74] [75] [76] , but not associated with death receptor caspase 3, and the caspase cascade. Thus, death induced by signalling. In contrast, efficient death receptor-mediated Fas signalling may or may not be inhibitable by Bcl-2 apoptosis of VSMCs can be achieved by high level family members suggesting that high levels of expression expression of death ligands such as Fas-L [28] , possibly by of anti-apoptotic Bcl-2 family members do not automatincreasing expression of membrane-bound forms of these ically correlate with suppression of cell death. The classifiligands. Thus, DNA damage induced by nitric oxide, cation of human VSMCs into type I or type II cells has yet anoxia or free radical formation for instance may stabilise to be made, however, the kinetics of cell death in response p53, effectively priming VSMCs to death receptor meto anti-Fas antibodies suggests that they are type II cells. diated apoptosis. Fas-induced apoptosis can also be blocked by expression Irrespective of the local environment, VSMCs derived of several intracellular proteins, including FLIPs (FLICE from atherosclerotic plaques show increased rates of inhibitory protein) and IAPs (inhibitor of apoptosis) (see apoptosis in culture compared with cells from normal Fig. 1 ). FLIPs are similar to caspase molecules, having the vessels, reflecting an intrinsic sensitivity to apoptosis [77] . same pro-domain structure as caspase 8, but not the active This appears to be a stable property, and is part of the caspase site within the C-terminus. The pro-domain of phenotype of plaque VSMCs that includes slow prolifercaspase 8 has two protein: protein interaction motifs called ation and early senescence. Heterogeneity of sensitivity to death effector domains (DEDs) that are also found in apoptosis within VSMCs in the vessel wall has also been FADD. These DEDs facilitate the binding of FADD to demonstrated in animal vessels after injury [78] , and in caspase 8 and the binding of FLIP to FADD. Caspase 8 is medial VSMCs from normal human arteries [79] . This is activated upon binding to FADD via a series of cleavage likely to reflect differences in expression of pro-and antireactions. FLIP undergoes the first of these cleavages, but apoptotic molecules, specifically those regulating signalnot the second, preventing the activation of caspase 8 [59] .
ling from survival cytokines, cell:cell and cell:matrix interactions and members of the bcl-2 family. Indeed, different molecular pathways. For example, the transcripInsulin-like growth factor 1 (IGF-1) is a potent survival tion factor E2F-1 induces S-phase entry by transcriptional factor for normal VSMCs, although IGF-1 cannot comactivation of target genes, but induces apoptosis most pletely inhibit plaque VSMC apoptosis in vitro after serum likely via transcriptional repression [95, 96] . In addition, withdrawal [77] . Similarly, inhibition of bFGF binding there is marked heterogeneity in the ability of E2F family induces VSMC apoptosis in vitro [80, 81] and in vivo [82] , members to promote cell proliferation and apoptosis. For possibly by induction of the oncogene mdm2 which example, despite E2F-2 and E2F-3 also inducing S-phase inactivates p53 [83] .
entry, neither are capable of inducing apoptosis [97] . Evidence suggesting the critical role of bcl-2 family In VSMCs, deregulated expression of a number of protomembers in regulating VSMC apoptosis has come from oncogenes, such as c-myc or the adenovirus gene product both in vitro and in vivo studies. Human VSMCs express E1A, promotes both apoptosis and cell proliferation simullow levels of Bcl-2 [77, 84] , but Bax is seen particularly in taneously, implying that the functional separation of these atherosclerotic plaques, both in human and animal models processes lies downstream of expression of both proteins of atherosclerosis and injury [84] [85] [86] . In addition, sponta- [98, 99] . Whilst the activity of E1A is partly due to its neous and growth-factor withdrawal-induced apoptosis can binding to the retinoblastoma gene product RB, releasing be inhibited by overexpression of bcl-2 [77] . In vivo, rat the E2F family of transcription factors and allowing VSMCs express minimal Bcl-2, but high levels of Bcl-X induction of S-phase genes, the mechanism of c-myccan be found after injury [86] . Indeed, inhibition of Bcl-X induced cell proliferation and apoptosis is largely uncan dramatically induce apoptosis of VSMCs after balloon known. injury [13] and differences in expression of Bcl-X may
The tumour suppressor gene RB arrests cells in G of 1 account for differences in sensitivity to apoptosis after the cell cycle when in its active, hypophosphorylated form. injury of intimal versus medial VSMCs [14] . The reduced Loss of this gene would be predicted to facilitate proliferlevels of VSMCs apoptosis seen after cholesterol lowering ation. However, RB deficient animals are not viable due to in rabbit models of atherosclerosis is also associated with a massive cell death in the haematopoietic and nervous loss of Bax immunoreactivity [85] , arguing for a prosystems. This evidence suggests that genes that act to apoptotic role of this protein in VSMC apoptosis. Howregulate cell cycle are 'booby-trapped'. That is, when ever, it should be noted that excessive reliance on immunomutated or lost the ability to confer autonomous growth is cytochemistry of one member of the bcl-2 family to dampened by the ability to also induce death or profound ascertain a role for that protein in vivo should be avoided. growth arrest. This suggests a cell with a proliferative Although Bcl-X is upregulated after injury, in rats it is the lesion is likely to be much more sensitive to death signals short Bcl-x or pro-apoptotic form that appears to predomiand a cell that has enhanced survival capacity is subject to s nate [86] . profound cell cycle arrest [100] . Thus, exposure of VSMC Regulation of sensitivity to apoptosis in VSMCs is also to inflammatory cytokines and other cytokines such as mediated by expression of IAP proteins [87] and individual platelet derived growth factor [101] and bFGF initiates a caspases [79, 88] , and it is likely that there are marked mitogenic signal within the VSMC, but if this is not differences in expression of multiple proteins which regbalanced by the presence of a survival signal cells enter ulate VSMC apoptosis of individual VSMCs in response to apoptosis and not proliferation. specific stimuli. This may underlie observations that The phenotype (low proliferation, early senescence, despite (apparently) the same stimulus for apoptosis, increased apoptosis) of VSMCs in atherosclerotic plaques VSMC apoptosis in the either the normal or diseased does not fit the above arguments. However, it may be that vessel wall is highly localised. plaque VSMC's have a complex set of lesions in both cell cycle and apoptotic pathways. Moreover, there are many 3.2. Cell proliferation and apoptosis different signals impinging on the plaque VSMC that may significantly alter their sensitivity to cell death stimuli. Considerable evidence suggests that cell proliferation
Although we cannot at present explain the phenotype of and apoptosis are linked. Thus, growth arrest often causes plaque VSMCs in terms of existing models, there is good resistance to apoptosis in response to specific signals [89] , evidence that these cells are senescent. Populations of and in some cases cells may undergo apoptosis at defined plaque VSMCs show increased hypophosphorylated RB points in the cell cycle [90] . Considerable overlap also (the active form) which may account for their slow exists between the components that execute both proproliferation and senescence. However, whenever these cesses. For example, activation of the mitogen-activated cells are stimulated to proliferate, for example by virus protein kinase cascade can promote apoptosis as well as gene products or E2F-1, cells undergo massive apoptosis, proliferation [91, 92] and activation or cleavage of cell which is, in part, mediated by p53 [102] . Of interest, p53 cycle proteins occurs in apoptosis as it does in mitosis alone does not induce apoptosis in either normal human or [93, 94] . Cell proliferation and apoptosis can also be rat VSMCs in vitro or in vivo unless the cells are primed induced by the same mediator, but either outcome requires to die [89, 103, 104] , or massive expression is used via adenovirus vectors [105] . However, stabilisation of p53 wall will aid the understanding of the timing and triggers may sensitise the cells to other apoptotic triggers such as of VSMC apoptosis in disease. Fas ligand [66] . In vivo, plaque VSMCs show increased expression of p53 and p21, the cell cycle inhibitor expressed upon stabilisation of p53 [19, 106] tion of an increase in VSMC proliferation in these p53- 
